HAE

Haemonetics Corp.

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP XL in Large-Bore Venous Access Closure Procedures New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP XL in Large-Bore Venous Access Closure Procedures PR Newswire BOSTON, April 24, 2026 BOSTON...

Boston Trust Walden Corp trimmed its holdings in Haemonetics Corporation (NYSE:HAE - Free Report) by 39.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 580,650 shares of the medical instruments supplier's stock after selling 376,040 shares d...

Haemonetics Corporation (NYSE:HAE - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven research firms that are currently covering the stock, MarketBeat reports...

Harbor Capital Advisors Inc. lowered its position in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 51.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,631 shares of the medical instruments supplier's stock after selling...

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 PR Newswire...

Allspring Global Investments Holdings LLC lessened its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 11.4% in the fourth quarter, according to the company in its most recent 13F filing...

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP XL Venous Vascular Closure System Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP XL Venous Vascular Closure System PR Newswire BOSTON, March 30, 2026 VASCADE MVP XL now approved for larger sheaths...

Assenagon Asset Management S.A. cut its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 56.4% during the 4th quarter, according to the company in its most recent disclosure with the...

Haemonetics Corporation (NYSE:HAE - Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 1,904,947...